Real-Life Data
Design, validate or accelerate clinical development with expert infrastructures.
Offer overview
What this offer helps you achieve
Design, validate or accelerate clinical development with expert infrastructures.
Scientific and technical scope
Access to multiple sources of real-life data in various hematological malignancies. In collaboration with LYSARC : DESCAR-T registry (data on French patients receiving a CAR-T) and REALYSA (data on French patients suffering from lymphoma). In multiple myeloma in collaboration with IFM : the EMMy registry collecting data on French patients suffering from multiple myeloma. The HEMSYS real-life database on French patients suffering from hematological malignancies, and a multidisciplinary concertation software also allows epidemiological analyses for Health Authorities.
Capabilities mobilised
Therapeutic areasExpert adviceClinical validationReal-life monitoringPlatforms
Application fields
Oncology
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
